Tech Company Financing Transactions

Shape Pharmaceuticals Funding Round

Shape Pharmaceuticals, operating out of Cambridge, scored $3.9 million in funding from HealthCare Ventures and private investors.

Transaction Overview

Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$3,889,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Pkwy. 301
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
Shape Pharmaceuticals, Inc. is developing a novel, topical HDAC inhibitor, SHP-141, currently in early clinical development, for the treatment of patients with cutaneous T cell lymphoma (CTCL).
Profile
Shape Pharmaceuticals LinkedIn Company Profile
Social Media
Shape Pharmaceuticals Company Twitter Account
Company News
Shape Pharmaceuticals News
Facebook
Shape Pharmaceuticals on Facebook
YouTube
Shape Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Douglas Onsi
  Douglas Onsi LinkedIn Profile  Douglas Onsi Twitter Account  Douglas Onsi News  Douglas Onsi on Facebook
Founder
James Bradner
  James Bradner LinkedIn Profile  James Bradner Twitter Account  James Bradner News  James Bradner on Facebook
Founder
Ralph Mazitschek
  Ralph Mazitschek LinkedIn Profile  Ralph Mazitschek Twitter Account  Ralph Mazitschek News  Ralph Mazitschek on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2009: Viralheat venture capital transaction
Next: 12/31/2009: Perception Software venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary